Association Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the US

Impact of age, ethnicity, sex and prior infection status on immunogenicity following a single dose of the BNT162b2 mRNA COVID-19 vaccine: real-world evidence from healthcare workers, Israel, December 2020 to January 2021

(2021) Kamal Abu Jabal et al.   Eurosurveillance

Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients

(2021) Brian J. Boyarsky et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data

(2021) Eric J Haas et al.   LANCET

Very low Immunization Rate in Kidney Transplant Recipients after one Dose of the BNT162b2 Vaccine

(2021) Hélène Georgery et al.   TRANSPLANTATION

Safety and Immunogenicity of Anti–SARS-CoV-2 Messenger RNA Vaccines in Recipients of Solid Organ Transplants

(2021) Olivier Marion et al.   ANNALS OF INTERNAL MEDICINE

Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series

(2021) William A. Werbel et al.   ANNALS OF INTERNAL MEDICINE

SARS-CoV-2 Vaccine Effectiveness in a High-Risk National Population in a Real-World Setting

(2021) Adeel A. Butt et al.   ANNALS OF INTERNAL MEDICINE

BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel

(2021) Tal Brosh-Nissimov et al.   CLINICAL MICROBIOLOGY AND INFECTION

Antibody and T Cell Response to SARS-CoV-2 Messenger RNA BNT162b2 Vaccine in Kidney Transplant Recipients and Hemodialysis Patients

(2021) Dominique Bertrand et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients

(2021) Nassim Kamar et al.   NEW ENGLAND JOURNAL OF MEDICINE

COVID-19 Vaccine Breakthrough Infections Reported to CDC — United States, January 1–April 30, 2021

(2021) et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Clinical Characterization and Prediction of Clinical Severity of SARS-CoV-2 Infection Among US Adults Using Data From the US National COVID Cohort Collaborative

(2021) Tellen D. Bennett et al.   JAMA Network Open

A minimal common outcome measure set for COVID-19 clinical research

(2020) John C Marshall et al.   LANCET INFECTIOUS DISEASES

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

(2020) Lisa A. Jackson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

(2020) Edward E. Walsh et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

(2020) Fernando P. Polack et al.   NEW ENGLAND JOURNAL OF MEDICINE

Summary of the Vaccines and Related Biological Products Advisory Committee meeting held to consider evaluation of vaccine candidates for the prevention of respiratory syncytial virus disease in RSV-naïve infants

(2019) Sarah K. Browne et al.   VACCINE

HBV vaccination in HIV: immunogenicity and persistence of seroprotection up to 7 years following a primary immunization course

(2018) laura ambra nicolini et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Prevalence of Immunosuppression Among US Adults, 2013

(2016) Rafael Harpaz et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Serologic Vaccination Response after Solid Organ Transplantation: A Systematic Review

(2013) Isabella Eckerle et al.   PLoS One

Unknown

(2009)   JOURNAL OF INFECTIOUS DISEASES

Unknown

(2008)   TRANSPLANT INTERNATIONAL